{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T06:56:31Z","timestamp":1760424991070,"version":"3.37.3"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.amjopharm.2010.03.001","type":"journal-article","created":{"date-parts":[[2010,5,3]],"date-time":"2010-05-03T06:29:31Z","timestamp":1272868171000},"page":"170-174","source":"Crossref","is-referenced-by-count":18,"title":["Separate episodes of delirium associated with levetiracetam and amiodarone treatment in an elderly woman"],"prefix":"10.1016","volume":"8","author":[{"given":"Kevin T.","family":"Foley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen S.","family":"Bugg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 9","key":"10.1016\/j.amjopharm.2010.03.001_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1528-1167.2005.00328.x","article-title":"Evidence-based treatment of idiopathic generalized epilepsies with new antiepileptic drugs","volume":"46","author":"Bergey","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib2","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.hrthm.2007.07.020","article-title":"A practical guide for clinicians who treat patients with amiodarone: 2007","volume":"9","author":"Goldschlager","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.7326\/0003-4819-108-1-68","article-title":"Amiodarone-induced delirium","volume":"108","author":"Trohman","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1176\/ajp.156.7.1119","article-title":"Amiodarone-induced delirium","volume":"156","author":"Barry","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00019442-200311000-00020","article-title":"Amiodarone-induced delirium","volume":"11","author":"Athwal","year":"2003","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-Mental State\u201d: A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.7326\/0003-4819-113-12-941","article-title":"Clarifying confusion: The confusion assessment method. A new method for detection of delirium","volume":"113","author":"Inouye","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1300\/J018v05n01_09","article-title":"Geriatric Depression Scale: Recent evidence and development of a shorter version","volume":"5","author":"Sheikh","year":"1986","journal-title":"Clin Gerontol"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00002512-199915010-00002","article-title":"Drug-induced cognitive impairment in the elderly","volume":"15","author":"Moore","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib10","series-title":"Delirium in Old Age","first-page":"51","article-title":"The neuropathophysiology of delirium","author":"Trzepacz","year":"2002"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib11","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1532-5415.2008.01737.x","article-title":"Anticholinergic activity of 107 medications commonly used by older adults","volume":"56","author":"Chew","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib12","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/gerona\/63.7.764","article-title":"Cholinergic deficiency hypothesis in delirium: A synthesis of current evidence","volume":"63","author":"Hshieh","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib13","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archinte.161.8.1099","article-title":"Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients","volume":"161","author":"Han","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00019442-199800610-00005","article-title":"The association of serum anticholinergic activity with delirium in elderly medical patients","volume":"6","author":"Flacker","year":"1998","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(98)00410-5","article-title":"Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy","volume":"353","author":"Klitgaard","year":"1998","journal-title":"Eur J Pharmacol"},{"year":"2009","series-title":"Keppra (levetiracetam) [package insert]","key":"10.1016\/j.amjopharm.2010.03.001_bib16"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2165\/00002018-200528100-00004","article-title":"Benefit-risk assessment of levetiracetam in the treatment of partial seizures","volume":"28","author":"Abou-Khalil","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1525-5050(03)00005-2","article-title":"A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials","volume":"4","author":"Cramer","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1212\/01.WNL.0000078031.32904.0D","article-title":"Psychiatric adverse events during levetiracetam therapy","volume":"61","author":"Mula","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1684\/j.1950-6945.2003.tb00573.x","article-title":"Acute psychosis associated with levetiracetam","volume":"5","author":"Youroukos","year":"2003","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib21","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1046\/j.1528-1157.2001.32101.x","article-title":"Levetiracetam psychosis in children with epilepsy","volume":"42","author":"Kossoff","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.yebeh.2003.09.007","article-title":"Use of levetiracetam in a population of patients aged 65 years and older: A subset analysis of the KEEPER trial","volume":"4","author":"Ferrendelli","year":"2003","journal-title":"Epilepsy Behav"},{"year":"2008","series-title":"Pacerone (amiodarone HCl) [package insert]","key":"10.1016\/j.amjopharm.2010.03.001_bib23"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib24","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/00005344-198411000-00023","article-title":"Interaction of the antiarrhythmic drug amiodarone with the muscarinic receptor on rat heart and brain","volume":"6","author":"Cohen-Armon","year":"1984","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib25","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1001\/jama.295.19.2247-c","article-title":"Prevention of atrial fibrillation following cardiac surgery","volume":"295","author":"Kwatra","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib26","first-page":"74","article-title":"Neurological and pulmonary adverse effects of amiodarone","volume":"44","author":"Fraser","year":"1986","journal-title":"Br J Clin Pract Suppl"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1212\/WNL.34.5.669","article-title":"Frequent neurologic toxicity associated with amiodarone therapy","volume":"34","author":"Charness","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib28","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneurol.2009.96","article-title":"Frequency, characteristics, and risk factors for amiodarone neurotoxicity","volume":"66","author":"Orr","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archinte.1987.00370050077013","article-title":"Unusual neurotoxicity associated with amiodarone therapy","volume":"147","author":"Palakurthy","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/brain\/108.3.753","article-title":"The pathology of amiodarone neurotoxicity. II. Peripheral neuropathy in man","volume":"108","author":"Jacobs","year":"1985","journal-title":"Brain"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib31","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","article-title":"Amiodarone and the thyroid","volume":"118","author":"Basaria","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4158\/EP.4.1.48","article-title":"Amiodarone and the thyroid","volume":"4","author":"Seminara","year":"1998","journal-title":"Endocr Pract"},{"key":"10.1016\/j.amjopharm.2010.03.001_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594610000206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594610000206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T13:50:57Z","timestamp":1740059457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594610000206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1543594610000206"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2010.03.001","relation":{},"ISSN":["1543-5946"],"issn-type":[{"type":"print","value":"1543-5946"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}